- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- Ural State Medical University, Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of Russia
Ural State Medical University, Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of Russia
Ural State Medical University, Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation (hereinafter referred to as the University, USMU) is the leading scientific, educational and methodological center in the Ural Federal District, which has been successfully training highly qualified medical personnel for 90 years, which has formed health care human resources of Sverdlovsk region and the Urals region and made a significant contribution to personnel training in the field of medical science and practice of the country.
“Vector of the USMU mission is aimed at strengthening the University's driving role for the innovative development of the healthcare system to attract talented young persons; integration of resources of educational, scientific institutions, industrial partners in the field of biomedicine, pharmacy and medical engineering; generation of high-tech innovative environment; creation of key elements for knowledge base of the platform “Medicine of the Future”; active introduction of integrated health-saving technologies; sustainable development of socio-cultural environment and human capital.
University target model transformation involves transition from a model of an educational institution to the model of a reference multidisciplinary (educational, scientific, innovative, practice-oriented) institution, which is a key element of networking cooperation between leading educational and scientific institutions, health care institutions, technological clusters and high-tech innovative enterprises of Sverdlovsk Region, Ural Federal District and neighboring states.
USMU is a coordinator of the Urals Scientific and Educational Medical Cluster, the base university of the Urals Scientific and Educational Consortium of Biomedicine, Pharmacy and Medical Engineering, created jointly by institutes of the Ural Branch of the Russian Academy of Sciences.
Active cooperation of the University with industrial partners – enterprises of the state corporations Rosatom, Roscosmos, Rostech, manufacturers of medical equipment, pharmaceuticals, creates conditions for formation of a high-tech complex of production and infrastructure facilities for technologies development and transfer, production of modern medicines, equipment and medical devices in the Urals.
USMU projects are implemented in the Ural Interregional Scientific and Educational World-Class Center «Advanced Production Technologies and Materials» in the field of «Bioequivalent Materials for Dentistry, Surgery, Traumatology».
Commitment to longstanding traditions and susceptibility to innovations in educational, research and clinical activities, enabled the University to achieve international recognition.
Since 2012, USMU has been included in the Top 100 best universities of Russia, Top 20 universities of «Medicine and Health Care», international rankings «Three missions of universities» and Times Higher Education.
According to the results of competitive selection in 2021, the University entered the strategic academic leadership program “Priority 2030” of the Ministry of Higher Education and Science of the Russian Federation.
Address: 3, Repina St., Ekaterinburg, 620028
Tel.: (343) 214-86-52
Email: usma@usma.ru
